To understand the molecular mechanisms underlying LINC02568 regulation of the malignant phenotypes of ER+ breast cancer cells, we first examined the coding potential of LINC02568 through CPAT (http://lilab.research.bcm.edu/cpat/). This evidence concerns the gene ESR1 and breast carcinoma.